Paper Details

  1. Home
  2. Paper Details

Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients.

Author: AvornJerry, LevinRaisa, WangPhilip S, ZhaoSean Z

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study investigates whether the use of urinary antispasmodics increases the risk of ventricular arrhythmias or sudden death. The study found no evidence to support a causal relationship between urinary antispasmodics and these events.
Paper Details　
Original Abstract of the Article :
The introduction of new medications to treat overactive bladder has resulted in a significant increase in the number of individuals with this condition who use medications for symptoms. Formal epidemiological studies of the safety of these medications in typical patient populations are lacking, part...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1532-5415.2002.50017.x

データ提供：米国国立医学図書館（NLM）

Urinary Antispasmodics: A Closer Look at Safety

This research delves into the critical field of pharmacovigilance, focusing on the safety of urinary antispasmodics, medications commonly used to treat overactive bladder. Overactive bladder, a common condition affecting many individuals, is often managed with medication. This study investigated the potential association between the use of urinary antispasmodics and the risk of ventricular arrhythmias and sudden death, particularly in older patients. The researchers found no evidence to suggest that these medications increase the risk of these serious cardiac events.

Navigating the Safety of Medications

This research underscores the importance of carefully monitoring the safety of medications, particularly in vulnerable patient populations. The study's findings provide reassurance regarding the safety of urinary antispasmodics for older patients, but highlight the ongoing need for vigilant surveillance and comprehensive risk-benefit assessment.

Managing Overactive Bladder with Confidence

This research offers valuable insights into the safety of medications used to treat overactive bladder. The study's findings provide reassurance for both patients and healthcare providers regarding the safety profile of these medications. It emphasizes the importance of open communication and collaboration between patients and their doctors to ensure the safe and effective management of overactive bladder.

Dr.Camel's Conclusion

This research examined whether medications used to treat overactive bladder, a condition that affects many people, can increase the risk of certain heart problems. They found no evidence to suggest that these medications increase the risk of these heart problems, especially in older adults. This research provides reassurance about the safety of these medications for treating overactive bladder.
Date :
  1. Date Completed 2002-07-23
  2. Date Revised 2019-07-09
Further Info :

Pubmed ID

12028256

DOI: Digital Object Identifier

10.1046/j.1532-5415.2002.50017.x

Related Literature

Article Analysis
・Effects of hyoscyamine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.